Table 3.

Characteristics of patients with streptococcal toxic shock syndrome who were matched by propensity score.^*

	No IVIG (N=67) No. (%)	IVIG (N=67) No. (%)	P**
Male sex	31 (46.3)	26 (38.8)	0.382
Age
<2y	8 (11.9)	8 (11.9)	0.900
2-4y	10 (14.9)	11 (16.4)
5-9y	20 (29.9)	23 (34.3)
10-14y	19 (28.4)	14 (20.9)
15-18y	10 (14.9)	11 (16.4)
Race
Non-Hispanic White	34 (51.5)	32 (50.8)	0.382
Non-Hispanic Black	14 (21.2)	8 (12.7)
Hispanic	7 (10.6)	14 (22.2)
Asian	4 (6.1)	3 (4.8)
Other	7 (10.6)	6 (9.5)
Comorbid conditions
Malignancy	1 (1.5)	2 (3.0)	0.559
Hematologic disorder or immunodeficiency	1 (1.5)	0 (0.0)	0.316
Diagnostic and therapeutic interventions
Arterial blood gas measurements***	2 (0-7)	5 (1-9)	0.048
Blood product receipt	34 (50.8)	36 (53.7)	0.729
Corticosteroid receipt	29 (43.3)	32 (47.8)	0.603
Vasoactive infusions	49 (73.1)	54 (80.6)	0.306
Intensive care unit admission	59 (88.1)	59 (88.1)	1.000
Dialysis	0 (0.0)	1 (1.5)	0.316
Mechanical ventilation	4 (6.0)	6 (9.0)	0.511
Surgical debridement	3 (4.5)	6 (9.0)	0.300

^*Values listed as number (percent) unless otherwise noted.

^**P<0.05 considered statistically significant

^***Value listed as median (interquartile range).